Histiocytoma
Showing 51 - 75 of 149
Dengue, Dengue Fever, Dengue Hemorrhagic Fever Trial in Worldwide (Live, attenuated, dengue serotype 1, 2, 3, 4 virus, Placebo:
Completed
- Dengue
- +2 more
- Live, attenuated, dengue serotype 1, 2, 3, 4 virus
- Placebo: Sodium chloride (NaCl) 0.9%
-
Denpasar, Bali, Indonesia
- +11 more
Mar 10, 2022
Respiratory Tract Infections Trial in Wellington (Dactolisib, Placebo)
Completed
- Respiratory Tract Infections
- Dactolisib
- Placebo
-
Wellington, New ZealandP3 Research Ltd.
May 31, 2021
Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma Trial (romidepsin)
Completed
- Adult Alveolar Soft-part Sarcoma
- +19 more
- (no location specified)
May 18, 2017
Soft Tissue Sarcoma, Fibrous Histiocytoma, Liposarcoma Trial in Boston (drug, radiation, procedure)
Completed
- Soft Tissue Sarcoma
- +5 more
- Bevacizumab
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Apr 14, 2017
Type 2 Diabetes Trial in Worldwide (efpeglenatide (SAR439977), )
Completed
- Type 2 Diabetes Mellitus
- efpeglenatide (SAR439977)
- placebo
-
Birmingham, Alabama
- +53 more
Jan 11, 2022
Alzheimer's Disease Trial in Worldwide (PF-04360365 0.1 mg/kg, PF-04360365 0.5 mg/kg, PF-04360365 1 mg/kg)
Completed
- Alzheimer's Disease
- PF-04360365 0.1 mg/kg
- +5 more
-
Peoria, Arizona
- +41 more
Oct 11, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +3 more
-
Boston, Massachusetts
- +11 more
Nov 23, 2022
Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma Trial in Miami (drug, procedure, radiation)
Completed
- Childhood Malignant Fibrous Histiocytoma of Bone
- Sarcoma
- celecoxib
- +2 more
-
Miami, FloridaUniversity of Miami Sylvester Comprehensive Cancer Center - Miam
Dec 14, 2016
Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)
Active, not recruiting
- Breast Cancer
- Palbociclib
- Standard Adjuvant Endocrine Therapy
-
Mobile, Alabama
- +437 more
Mar 21, 2022
Hepatocellular Carcinoma Trial in Worldwide (Tremelimumab, Durvalumab, Bevacizumab)
Active, not recruiting
- Hepatocellular Carcinoma
- Tremelimumab
- +2 more
-
Phoenix, Arizona
- +43 more
Jun 22, 2022
Sarcoma Trial in Baltimore (temsirolimus plus liposomal doxorubicin)
Completed
- Sarcoma
- temsirolimus plus liposomal doxorubicin
-
Baltimore, MarylandJohns Hopkins University
Mar 8, 2019
Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Cladribine, Placebo)
Completed
- Relapsing-Remitting Multiple Sclerosis
- Cladribine
- Placebo
-
Boulder, Colorado
- +116 more
Nov 10, 2020
Postmenopausal Osteoporosis Trial in Worldwide (Romosozumab, Placebo, Denosumab)
Crizotinib (Regulatory Post Marketing Commitment Plan)
Completed
- Non-small Cell Lung Cancer
- Crizotinib (Xalkori)
- (no location specified)
Sep 12, 2019
Maraviroc's Safety
Completed
- Human Immunodeficiency Virus
- Maraviroc along with an optimized background antiretroviral drug regimen
- Optimized background antiretroviral drug regimen without maraviroc
-
Hobson City, Alabama
- +266 more
Mar 24, 2020
Herpes Zoster, Herpes Zoster Vaccine Trial in Worldwide (Herpes Zoster Vaccine GSK1437173A, Placebo)
Completed
- Herpes Zoster
- Herpes Zoster Vaccine
- Herpes Zoster Vaccine GSK1437173A
- Placebo
-
Mesa, Arizona
- +212 more
Apr 15, 2020
Coronary Heart Disease Trial in Worldwide (Dalcetrapib (RO4607381), Evidence-based medical care for Acute Coronary Syndrome,
Completed
- Coronary Heart Disease
- Dalcetrapib (RO4607381)
- +2 more
-
Birmingham, Alabama
- +1090 more
Dec 16, 2019
Moderate to Severe Plaque-type Psoriasis Trial in Germany (Secukinumab)
Completed
- Moderate to Severe Plaque-type Psoriasis
-
Bad Bentheim, Germany
- +88 more
Apr 12, 2019
Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )
Completed
- Diabetes Mellitus, Type 2
- Ticagrelor 60 mg
- Ticagrelor placebo
-
Alexander City, Alabama
- +1241 more
Mar 4, 2020
Relapsing Remitting Multiple Sclerosis Trial in Australia, Spain (Fingolimod (FTY720))
Completed
- Relapsing Remitting Multiple Sclerosis
- Fingolimod (FTY720)
-
East Gosford, New South Wales, Australia
- +46 more
Aug 15, 2018
Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )
Essential Hypertension Trial in Worldwide (olmesartan medoxomil + amlodipine + hydroclororthiazide + , Olmesartan medoxomil +
Completed
- Essential Hypertension
- olmesartan medoxomil + amlodipine + hydroclororthiazide + placebo
- +3 more
-
Antwerp, Belgium
- +132 more
Dec 20, 2018